210 related articles for article (PubMed ID: 31406207)
21. The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro.
Cheng Q; Li X; Wang Y; Dong M; Zhan FH; Liu J
Acta Pharmacol Sin; 2018 Apr; 39(4):561-568. PubMed ID: 28858294
[TBL] [Abstract][Full Text] [Related]
22. Exosomal transfer of miR-195-5p restrains lung adenocarcinoma progression.
Zhou Y; Wang G; Cai J; Du Y; Li H; Duan L; Zhao G; Huang Y
Exp Cell Res; 2023 Mar; 424(1):113485. PubMed ID: 36657657
[TBL] [Abstract][Full Text] [Related]
23. Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.
He S; Li Z; Yu Y; Zeng Q; Cheng Y; Ji W; Xia W; Lu S
Exp Cell Res; 2019 Jun; 379(2):203-213. PubMed ID: 30978341
[TBL] [Abstract][Full Text] [Related]
24. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
25. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
[TBL] [Abstract][Full Text] [Related]
27. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.
Zhao L; Tang X; Luo R; Duan J; Wang Y; Yang B
Curr Neurovasc Res; 2018; 15(3):246-255. PubMed ID: 30101705
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Busacca S; Germano S; De Cecco L; Rinaldi M; Comoglio F; Favero F; Murer B; Mutti L; Pierotti M; Gaudino G
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):312-9. PubMed ID: 19502386
[TBL] [Abstract][Full Text] [Related]
30. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
31. Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR-26b-5p.
Wu T; Chen W; Liu S; Lu H; Wang H; Kong D; Huang X; Kong Q; Ning Y; Lu Z
FEBS Lett; 2014 Jun; 588(12):2107-14. PubMed ID: 24815696
[TBL] [Abstract][Full Text] [Related]
32. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
Zhang Y; Zhang Y; Yin Y; Li S
Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
[TBL] [Abstract][Full Text] [Related]
33. Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells.
Azuma Y; Yokobori T; Mogi A; Yajima T; Kosaka T; Iijima M; Shimizu K; Shirabe K; Kuwano H
Surg Today; 2020 Sep; 50(9):1099-1106. PubMed ID: 32052182
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
[TBL] [Abstract][Full Text] [Related]
35. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
[TBL] [Abstract][Full Text] [Related]
36. A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma.
Schelch K; Kirschner MB; Williams M; Cheng YY; van Zandwijk N; Grusch M; Reid G
Mol Oncol; 2018 Jan; 12(1):58-73. PubMed ID: 29094504
[TBL] [Abstract][Full Text] [Related]
37. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
38. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2.
Xu Y; Shen L; Li F; Yang J; Wan X; Ouyang M
J Cell Physiol; 2019 Nov; 234(11):21380-21394. PubMed ID: 31102273
[TBL] [Abstract][Full Text] [Related]
39. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
[TBL] [Abstract][Full Text] [Related]
40. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.
Yamamoto K; Seike M; Takeuchi S; Soeno C; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
Oncol Rep; 2014 Dec; 32(6):2365-72. PubMed ID: 25231602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
